FE Today Logo

IPO road show of Asiatic Laboratories held

October 26, 2021 00:00:00


Asiatic Laboratories Limited started its journey to Initial Public Offering (IPO) under book building method as per Bangladesh Public Issue Rules-2015.

The company arranged a road show programme on Sunday in the capital. Managing Director Md. Monir Ahmed, Chairman Mrs. Tahmina Begum, Executive Director Mr. Maqsood Ahmed, Director Operation Ms. Sadia Ahmed, Independent Director, Company Secretary, Chief Financial Officer of Asiatic Laboratories Limited and other officials were present on this occasion.

Representatives of Issue Manager and Registrar of Issue, Underwriters, Merchant Banks, Fund Manager, Bond Manager, Insurance Company, DSE-CSE Trec Holders, Mutual Funds, NBFIs and other representatives were also present on the occasion.

To gain market share and to become a reputed pharmaceutical company in Bangladesh Asiatic Laboratories Limited is participating in the IPO for Taka 950 million subject to the approval of BSEC through Book Building Method. After spending on the IPO, the company will use the rest of the money to build new factory buildings, capital machinery and partially repayment of loans.

Speaking on the occasion, Managing Director of the company, Monir Ahmed, said, "Successfully completing the IPO will enable us to achieve our desired production capacity and market share. According to the projected financial statement, our sales revenue in 2025 will be 2.87 billion and production capacity will increase to 28.7 million pieces per year. This means that the sales revenue will increase by 98 per cent from the current sales revenue and the payback period is presumed 2.5 years. We will be able to meet the market demand of Bangladesh and then export to other developed countries. This is the best time to invest in Asiatic Laboratories Ltd. and we will be able to give our shareholders the right returns and start our next milestone in the capital market. "

At present, Asiatic Laboratories Ltd. is producing 6 million tablets, 5 million capsules, 2 million injections, 1.5 million tube creams and 1.6 million bottles of syrup every year.

There are approximately 285 approved drugs out of which 255 items are currently being produced.


Share if you like